CTRI/2022/01/039483尚未招募未知
A prospective, randomized study comparing the safety of sedation with and without prophylactic placement of nasopharyngeal airway in children undergoing MRI
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients aged 0-18 years scheduled for an MRI for diagnostic purposes
排除标准
- •1.Patients >18 years of age
- •2. Premature neonates
- •2. Patients who are already intubated
- •3. Critically ill patients
- •4. Patients with nasal or cranio-facial fractures in whom placement of airway adjunct is contraindicated
- •5. Patients with anticipated difficult airway
研究者
相似试验
尚未招募
不适用
A clinical study with random allocation of young cancer patients having fever with low neutrophil blood count for comparing the safety and cost-effectiveness of early stoppage of antibiotic without neutrophil count recovery versus with neutrophil count recovery in these patientsCTRI/2016/02/006618Dr Brijesh Arora100
进行中（未招募）
1 期
Evaluate the safety and efficacy of IPX203 carbidopa-levodopa extended release capsules compared to carbidopa-levodopa immediate release tablets in patients with Parkinson's with motor fluctuations.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028035Term: Movement disorderSystem Organ Class: 10029205 - Nervous system disordersParkinson's diseaseEUCTR2018-002233-37-ITImpax Laboratories, LLC510
进行中（未招募）
1 期
Evaluate the safety and efficacy of IPX203 carbidopa-levodopa extended release capsules compared to carbidopa-levodopa immediate release tablets in patients with Parkinson’s with motor fluctuations.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028035Term: Movement disorderSystem Organ Class: 10029205 - Nervous system disordersParkinson's diseaseEUCTR2018-002233-37-DEImpax Laboratories, LLC510
进行中（未招募）
1 期
Evaluate the safety and efficacy of IPX203 carbidopa-levodopa extended release capsules compared to carbidopa-levodopa immediate release tablets in patients with Parkinson’s with motor fluctuations.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028035Term: Movement disorderSystem Organ Class: 10029205 - Nervous system disordersParkinson's diseaseEUCTR2018-002233-37-GBImpax Laboratories, LLC510
进行中（未招募）
1 期
Evaluate the safety and efficacy of IPX203 carbidopa-levodopa extended release capsules compared to carbidopa-levodopa immediate release tablets in patients with Parkinson’s with motor fluctuations.Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028035Term: Movement disorderSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002233-37-CZImpax Laboratories, LLC510